About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingPhase 4NCT04094038

The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients

Protein-energy wasting (PEW), a hypercatabolic state characterized by loss of muscle mass and fuel reserves, is highly prevalent in hemodialysis patients. Nutritional status and body composition are c...

Lead sponsor: Erasmus Medical Center•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Erasmus Medical Center

Collaborators

Baxter Healthcare Corporation

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Undergoing chronic hemodialysis

Exclusion Criteria

•Life expectancy \< 6 months
•Planned kidney transplant within 4 months
•Severe overhydration leading to respiratory insufficiency
•Parenteral nutrition within four weeks prior to screening
•Severe hepatic insufficiency
•Pregnancy
•Unipolar pacemaker with a very low sensitivity threshold
•Active treatment for infection
•Acute myocardial infarction
•Circulatory shock
•Hypersensitivity for any Olimel N12 ingredient or excipient

Related studies

RECRUITINGPhase 3

Regime for Vitamin D Maintenance in Post-Operative Patients

NCT06708741 · Sarcopenia

Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)

NCT06345547 · Sarcopenia, Cirrhosis, and more

The Foods & Oil to Repair, Correct and Enhance Strength (FORCES) Study

NCT06361511 · Sarcopenia

RECRUITINGPhase 2

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

NCT06811324 · Obesity Prevention, Sarcopenia in Elderly, and more

Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics

NCT07519837 · Cachexia; Cancer; Sarcopenia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 12, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE4

Enrollment166

Start dateSep 2019

Last updatedFeb 12, 2026

Condition

End Stage Renal Disease Malnutrition Sarcopenia Hemodialysis Complication

Locations shown

Erasmus MC

Rotterdam

Franciscus Gasthuis & Vlietland

Rotterdam

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 12, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions